|
Resolution: standard / high Figure 3.
Kaplan-Meier analysis of days to CV event in SPAA and CCB/statin primary prevention
patients with no history of cancer or chronic renal failure
Chapman et al. BMC Cardiovascular Disorders 2010 10:29 doi:10.1186/1471-2261-10-29 |